PEOPLE - BioSite makes appointment:
This article was originally published in Clinica
Executive Summary
US molecular diagnostic firm Adnavance Technologies (Vancouver, British Columbia) has appointed Kenneth Buechler as an independent director. Mr Buechler is the co-founder of diagnostics firm BioSite (bought in 2007 by Inverness Medical Innovations). Valuable to the company will be Mr Buechler's experience in diagnostic technology development and commercialisation, including expertise in regulatory process, market development and strategic partnering.